A synthetic peptide for use as a blocking control in assays to test for specificity of ADAR antibody, Alternative Names: ADAR control peptide, ADAR antibody Blocking Peptide, Anti-ADAR Blocking Peptide, Adenosine Deaminase Rna-Specific Blocking Peptide, ADAR1 Blocking Peptide, DRADA Blocking Peptide, DSH Blocking Peptide, DSRAD Blocking Peptide, G1P1 Blocking Peptide, IFI-4 Blocking Peptide, IFI4 Blocking Peptide, K88dsRBP Blocking Peptide, p136 Blocking Peptide
ADAR
Reaktivität: Human, Maus, Schwein, Ratte
Wirt: Synthetic
BP
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
ADAR
(Adenosine Deaminase, RNA-Specific (ADAR))
Hintergrund
ADAR is responsible for RNA editing by site-specific deamination of adenosines. This enzyme destabilizes double stranded RNA through conversion of adenosine to inosine. Mutations in this gene have been associated with dyschromatosis symmetrica hereditaria. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.